COMP <GO>
KEQU vs BNR // PIOTROSKI F-SCORE QUALITY
Kewaunee Scientific Corporation (NASDAQ) VS. Burning Rock Biotech Limited (NASDAQ) • 15-METRIC TALLY: KEQU 8
— BNR 2
▲ PIOTROSKI F-SCORE QUALITY LEADER: KEQU
LAST: $33.44 (-0.21%) • MKT CAP: $97.0M
piotroski-score
8/9
LAST: $10.90 (-1.36%) • MKT CAP: $116.5M
piotroski-score
5/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KEQU VS. BNR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KEQU | BNR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.50% | 74.70% | -46.20 | BNR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.70% | -35.00% | +51.70 | KEQU | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 19.20% | -4.14% | +23.34 | KEQU | /fcf-yield <GO> |
| Operating Margin | 5.90% | -10.20% | +16.10 | KEQU | /operating-margins <GO> |
| Net Profit Margin | 3.40% | -10.30% | +13.70 | KEQU | /net-margins <GO> |
| Revenue Growth (YoY) | 17.30% | 9.20% | +8.10 | KEQU | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.37 | 0.20 | +3.17 | KEQU | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 5/9 | +3.00 | KEQU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.8 | 39.1 | +10.70 | KEQU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $97.0M | $116.5M | -$19.5M | BNR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KEQU REV | BNR REV | KEQU GROSS % | BNR GROSS % | KEQU FCF | BNR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $282.0M | $77.2M | 28.5% | 74.7% | $18.6M | -$4.8M |
| FY 2024 | $240.5M | $70.7M | 28.6% | 70.3% | $14.8M | -$13.4M |
| FY 2023 | $203.8M | $75.7M | — | — | $19.6M | -$36.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KEQU // BETA —
BNR // BETA —